Personalized Medicine funding 2011-2016

February 2016

North America Re:Rare (Repurposing research in rare diseases: Cures within Reach/CIHR Collaborative Funding Program)
The goal of this funding opportunity is to support efforts on proof of concept clinical trials repurposing human approved drugs for new disease indications.

December 2015

E-Rare-3 Joint Transnational Call 2016
The specific objective of this call is to promote clinical and pre-clinical proof of concept studies for the potential application of medicinal products that are either already marketed or have achieved a significant stage in the development process in rare indications.

November 2015

Operating Grant: Bioinformatics and Computational Biology
This funding opportunity supports the development of next generation Bioinformatics and Computational Biology (B/CB) tools and methodologies that will be required by the research community to deal with the influx of large amounts of data produced by modern "–omic" technologies and provide broad and timely access of these new B/CB tools to the research community.

December 2014

E-Rare-3 Joint Transnational Call 2015
The aim of the call is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise, with a clear translational research approach. Projects shall involve a group of rare diseases or a single rare disease.

March 2014

CQDM/CIHR Collaborative Funding Program to Accelerate Drug Discovery in Personalized Medicine
This funding opportunity aims to accelerate drug discovery and drug development. Research focusses on invention and development of the next-generation technologies, computational tools & devices.

December 2013

E-Rare-2: Innovative Therapeutic Approaches
This joint transnational call supports multilateral research projects that promote the development of innovative therapeutic approaches for rare diseases. Therapeutic approaches include cell-based therapy, gene therapy, and pharmacological therapy.

October 2013

Research Catalyst Network: Rare Diseases
The goal of the Research Catalyst Network is to expedite collaboration between basic and clinician scientists in functional studies of novel rare disease genes and to establish a national consortium that will enable clinical geneticists who are identifying rare disease gene mutations to collaborate with model organism researchers with expertise in the cognate gene's function.

Quantitative Imaging for Responses to Cancer Therapies
The objective of this funding opportunity is to support Canadian research teams as an integral part of the National Cancer Institute (NCI) Quantitative Imaging Network (QIN). Canadian researchers have the opportunity to participate in the development of advanced quantitative imaging methods that may potentially improve the means to predict response to therapy or measure the response to therapy at an earlier time frame, thus permitting a quantitative means to implement adaptive therapy trials.

December 2012

E-Rare-2 Joint Transnational Call on Rare Diseases
The aim of this funding opportunity is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise, with a clear translational research approach. Projects involve a group of rare diseases or a single rare disease.

July 2012

Operating Grant: Bioinformatics and Computational Biology
This funding opportunity supports the development of next generation Bioinformatics and Computational Biology tools and methodologies that will be required by the research community to deal with the influx of large amounts of data produced by modern genomics technologies; and provides broad access of these new Bioinformatics and Computational Biology tools to the research community.

December 2011

Large-Scale Applied Research Project Competition in Genomics and Personalized Health
This funding opportunity supports projects that demonstrate how genomics-based research can contribute to a more evidence-based approach to health and improve the cost-effectiveness of the healthcare system.

Date modified: